198 related articles for article (PubMed ID: 20600265)
21. Human T cell leukemia virus type I (HTLV-I) and human diseases.
Uchiyama T
Annu Rev Immunol; 1997; 15():15-37. PubMed ID: 9143680
[TBL] [Abstract][Full Text] [Related]
22. A novel therapeutic molecule against HTLV-1 infection targeting provirus.
Tanaka A; Takeda S; Kariya R; Matsuda K; Urano E; Okada S; Komano J
Leukemia; 2013 Aug; 27(8):1621-7. PubMed ID: 23411465
[TBL] [Abstract][Full Text] [Related]
23. Research and discovery of the first human cancer virus, HTLV-1.
Gallo RC
Best Pract Res Clin Haematol; 2011 Dec; 24(4):559-65. PubMed ID: 22127321
[TBL] [Abstract][Full Text] [Related]
24. PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival.
Panfil AR; Al-Saleem J; Howard CM; Mates JM; Kwiek JJ; Baiocchi RA; Green PL
Viruses; 2015 Dec; 8(1):. PubMed ID: 26729154
[TBL] [Abstract][Full Text] [Related]
25. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).
Ahmadi Ghezeldasht S; Blackbourn DJ; Mosavat A; Rezaee SA
Crit Rev Clin Lab Sci; 2023 May; 60(3):189-211. PubMed ID: 36593730
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of human T-lymphotropic virus type 1 transmission and disease.
Lairmore MD; Haines R; Anupam R
Curr Opin Virol; 2012 Aug; 2(4):474-81. PubMed ID: 22819021
[TBL] [Abstract][Full Text] [Related]
27. Human T-Cell Leukemia Virus Type 1 Infection and Adult T-Cell Leukemia.
Chan CP; Kok KH; Jin DY
Adv Exp Med Biol; 2017; 1018():147-166. PubMed ID: 29052136
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of leukemogenesis by human T-cell leukemia virus type I: from infection with HTLV-I to the onset of adult T-cell leukemia].
Matsuoka M
Rinsho Ketsueki; 2006 Dec; 47(12):1493-501. PubMed ID: 17233467
[No Abstract] [Full Text] [Related]
29. Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma.
Yoshimitsu M; White Y; Arima N
Recent Results Cancer Res; 2014; 193():211-25. PubMed ID: 24008301
[TBL] [Abstract][Full Text] [Related]
30. Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.
Satou Y; Matsuoka M
Rev Med Virol; 2013 Sep; 23(5):269-80. PubMed ID: 23606621
[TBL] [Abstract][Full Text] [Related]
31. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia.
Toulza F; Nosaka K; Takiguchi M; Pagliuca T; Mitsuya H; Tanaka Y; Taylor GP; Bangham CR
Int J Cancer; 2009 Nov; 125(10):2375-82. PubMed ID: 19544530
[TBL] [Abstract][Full Text] [Related]
32. Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
Sakihama S; Morichika K; Saito R; Miyara M; Miyagi T; Hayashi M; Uchihara J; Tomoyose T; Ohshiro K; Nakayama S; Nakachi S; Morishima S; Sakai K; Nishio K; Masuzaki H; Fukushima T; Karube K
Cancer Sci; 2021 Mar; 112(3):1300-1309. PubMed ID: 33426772
[TBL] [Abstract][Full Text] [Related]
33. MiR-150 in HTLV-1 infection and T-cell transformation.
D'Agostino DM; Raimondi V; Silic-Benussi M; Ciminale V
Front Immunol; 2022; 13():974088. PubMed ID: 36072598
[TBL] [Abstract][Full Text] [Related]
34. Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.
Ruggero K; Guffanti A; Corradin A; Sharma VK; De Bellis G; Corti G; Grassi A; Zanovello P; Bronte V; Ciminale V; D'Agostino DM
J Virol; 2014 Apr; 88(7):3612-22. PubMed ID: 24403582
[TBL] [Abstract][Full Text] [Related]
35. Osteolytic bone resorption in adult T-cell leukemia/lymphoma.
Shu ST; Martin CK; Thudi NK; Dirksen WP; Rosol TJ
Leuk Lymphoma; 2010 Apr; 51(4):702-14. PubMed ID: 20214446
[TBL] [Abstract][Full Text] [Related]
36. HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia.
Thénoz M; Vernin C; Mortada H; Karam M; Pinatel C; Gessain A; Webb TR; Auboeuf D; Wattel E; Mortreux F
Retrovirology; 2014 Dec; 11():119. PubMed ID: 25519886
[TBL] [Abstract][Full Text] [Related]
37. miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.
Bai XT; Nicot C
J Biol Chem; 2015 Feb; 290(9):5381-90. PubMed ID: 25568327
[TBL] [Abstract][Full Text] [Related]
38. HTLV-1 infection: what determines the risk of inflammatory disease?
Tattermusch S; Bangham CR
Trends Microbiol; 2012 Oct; 20(10):494-500. PubMed ID: 22917680
[TBL] [Abstract][Full Text] [Related]
39. HTLV-1 persistent infection and ATLL oncogenesis.
Zuo X; Zhou R; Yang S; Ma G
J Med Virol; 2023 Jan; 95(1):e28424. PubMed ID: 36546414
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes.
Pichler K; Schneider G; Grassmann R
Retrovirology; 2008 Nov; 5():100. PubMed ID: 19014482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
